Inovio Pharmaceuticals (INO) Financials: Revenue & Earnings

INO price $0.93 +0.04 +4.74%

Ticker
INO
Price
$0.93
Change
+0.04 +4.74%
Market cap ?
$64.41M
Beta ?
1.61
Sector
Healthcare
Industry
Biotechnology

Fair value

INO fair value $5.53. Price $0.93. Price is 83% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 9.09K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.6). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 69.09M. Net debt -34.91M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare INO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-10—-0.20—2.27M
2026-08-12-0.07-0.22—533.33K
2026-05-13-0.28-0.35—333.33K
2026-03-120.06-0.37—333.33K
2025-11-10-0.87-0.42—10.00K
2025-08-12-0.61-0.63—10.00K
2025-05-13-0.51-0.7465.34K10.00K
2025-03-18-0.69-0.87116.99K50.00K
2024-11-14-0.89-1.20—30.00K
2024-08-08-1.19-1.15100.76K120.00K
2024-05-13-1.31-1.08—150.00K
2024-03-06-1.12-1.27102.65K340.00K
2023-11-09-1.08-1.56388.45K116.67K
2023-08-09-1.56-1.68225.97K260.00K
2023-05-10-1.92-1.68114.94K270.00K
2023-03-01-2.52-1.92124.67K339.28K
2022-11-08-1.80-3.489.15M623.17K
2022-08-09-5.52-3.60784.39K529.00K
2022-05-10-4.32-3.36199.07K773.00K
2022-03-01-6.00-3.96839.12K2.52M
2021-11-09-3.48-3.96291.70K970.00K
2021-08-09-4.68-3.00272.82K273.00K
2021-05-10-3.24-2.16371.12K306.17K
2021-03-01-1.68-2.645.58M—
2020-11-09-2.64-2.16236.18K548.18K
2020-08-10-2.76-2.16267.19K54.73K
2020-05-11-3.12-2.881.33M1.12M
2020-03-12-3.84-2.76279.49K176.52K
2019-11-12-3.24-3.24866.86K901.53K
2019-08-08-3.60-3.36135.67K122.10K
2019-05-09-3.60-3.482.83M2.45M
2019-03-12-4.08-3.602.50M2.00M
2018-11-08-3.24-3.842.00M2.22M
2018-08-07-0.96-4.2024.45M76.84M
2018-05-09-4.32-3.241.53M467.50K
2018-03-14-2.88-3.848.79M11.08M
2017-11-08-4.80-2.762.64M1.69M
2017-08-08-1.56-1.9220.41M29.83M
2017-05-10-3.72-4.2010.38M10.38M
2017-03-15-4.32-3.488.51M7.29M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Monthly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2017-09-28$0.072017-09-292017-10-16Monthly
2017-08-29$0.072017-08-312017-09-15Monthly
2017-07-27$0.072017-07-312017-08-15Monthly
2017-06-28$0.072017-06-302017-07-17Monthly

Insider trades

DateInsiderActionSharesPriceValue
2026-05-20YARNO WENDY LBuy41.80K$1.2351.41K
2026-05-20YARNO WENDY LBuy34.20K——
2026-05-20Shepard JayBuy41.80K$1.2351.41K
2026-05-20Shepard JayBuy34.20K——
2026-05-20Miller Ann CalbyBuy41.80K$1.2351.41K
2026-05-20Miller Ann CalbyBuy34.20K——
2026-05-20Weiner David B.Buy41.80K$1.2351.41K
2026-05-20Weiner David B.Buy34.20K——
2026-05-20Zoth Lota S.Buy41.80K$1.2351.41K
2026-05-20Zoth Lota S.Buy34.20K——
2026-05-20DANSEY ROGER DBuy41.80K$1.2351.41K
2026-05-20DANSEY ROGER DBuy34.20K——
2026-05-20BENITO SIMON XBuy41.80K$1.2351.41K
2026-05-20BENITO SIMON XBuy34.20K——
2026-05-20Humeau LaurentBuy6.03K——
2026-05-20Humeau LaurentSell2.16K$1.232.66K
2026-05-20Humeau LaurentBuy34.16K$1.7359.10K
2026-05-20Humeau LaurentBuy27.44K——
2026-05-20Humeau LaurentSell6.03K——
2026-05-20Sumner Michael JohnBuy46.88K$1.7381.10K
2026-05-20Sumner Michael JohnBuy9.45K——
2026-05-20Sumner Michael JohnSell2.69K$1.233.31K
2026-05-20Sumner Michael JohnBuy37.68K——
2026-05-20Sumner Michael JohnSell9.45K——
2026-05-20KIES PETERBuy8.70K——
2026-05-20KIES PETERSell4.69K$1.235.77K
2026-05-20KIES PETERBuy39.76K$1.7368.78K
2026-05-20KIES PETERBuy32.48K——
2026-05-20KIES PETERSell8.70K——
2026-05-20Shea Jacqueline ElizabethBuy123.76K$1.73214.10K
2026-05-20Shea Jacqueline ElizabethBuy28.30K——
2026-05-20Shea Jacqueline ElizabethSell12.31K$1.2315.14K
2026-05-20Shea Jacqueline ElizabethBuy100.24K——
2026-05-20Shea Jacqueline ElizabethSell28.30K——
2026-05-15Shea Jacqueline ElizabethBuy17.74K——
2026-05-15Shea Jacqueline ElizabethSell7.72K$1.3010.03K
2026-05-15Shea Jacqueline ElizabethSell17.74K——
2026-05-15KIES PETERBuy4.77K——
2026-05-15KIES PETERSell2.57K$1.303.34K
2026-05-15KIES PETERSell4.77K——
2026-05-15Humeau LaurentBuy4.77K——
2026-05-15Humeau LaurentSell1.71K$1.302.23K
2026-05-15Humeau LaurentSell4.77K——
2026-05-15Sumner Michael JohnBuy2.38K——
2026-05-15Sumner Michael JohnSell680$1.30884
2026-05-15Sumner Michael JohnSell2.38K——
2026-03-31Sumner Michael JohnBuy4.29K——
2026-03-31Sumner Michael JohnSell1.22K$1.742.13K
2026-03-31Sumner Michael JohnSell4.29K——
2026-03-04Humeau LaurentBuy26.84K$1.7346.43K
2026-03-04Humeau LaurentBuy21.56K——
2026-03-04Shea Jacqueline ElizabethBuy97.24K$1.73168.23K
2026-03-04Shea Jacqueline ElizabethBuy78.76K——
2026-03-04Sumner Michael JohnBuy36.83K$1.7363.72K
2026-03-04Sumner Michael JohnBuy29.61K——
2026-03-04KIES PETERBuy31.24K$1.7354.05K
2026-03-04KIES PETERBuy25.52K——
2026-02-26Humeau LaurentBuy7.37K——
2026-02-26Humeau LaurentSell3.03K$1.795.43K
2026-02-26Humeau LaurentBuy5.01K——
2026-02-26Humeau LaurentSell2.06K$1.793.69K
2026-02-26Humeau LaurentSell7.37K——
2026-02-26Humeau LaurentSell5.01K——
2026-02-26KIES PETERBuy10.63K——
2026-02-26KIES PETERSell6.29K$1.7911.27K
2026-02-26KIES PETERBuy5.01K——
2026-02-26KIES PETERSell2.96K$1.795.31K
2026-02-26KIES PETERSell10.63K——
2026-02-26KIES PETERSell5.01K——
2026-02-26Shea Jacqueline ElizabethBuy28.40K——
2026-02-26Shea Jacqueline ElizabethSell13.66K$1.7924.45K
2026-02-26Shea Jacqueline ElizabethBuy18.63K——
2026-02-26Shea Jacqueline ElizabethSell8.06K$1.7914.42K
2026-02-26Shea Jacqueline ElizabethSell28.40K——
2026-02-26Shea Jacqueline ElizabethSell18.63K——
2026-02-26Sumner Michael JohnBuy11.55K——
2026-02-26Sumner Michael JohnSell3.90K$1.796.99K
2026-02-26Sumner Michael JohnSell11.55K——
2026-02-26Sumner Michael JohnBuy5.01K——
2026-02-26Sumner Michael JohnSell5.01K——
2026-02-26Weiner David B.Buy972——
2026-02-26Weiner David B.Sell972——
2025-06-30Sumner Michael JohnBuy2.92K——
2025-06-30Sumner Michael JohnSell2.92K——
2025-05-21Zoth Lota S.Buy2.17K——
2025-05-21Zoth Lota S.Sell2.17K——
2025-05-21Miller Ann CalbyBuy2.17K——
2025-05-21Miller Ann CalbySell2.17K——
2025-05-21Shepard JayBuy2.17K——
2025-05-21Shepard JaySell2.17K——
2025-05-21BENITO SIMON XBuy2.17K——
2025-05-21BENITO SIMON XSell2.17K——
2025-05-21YARNO WENDY LBuy2.17K——
2025-05-21YARNO WENDY LSell2.17K——
2025-05-21DANSEY ROGER DBuy2.17K——
2025-05-21DANSEY ROGER DSell2.17K——
2025-05-21Weiner David B.Buy2.17K——
2025-05-21Weiner David B.Sell2.17K——
2025-05-20Shea Jacqueline ElizabethBuy105.26K$2.13224.21K
2025-05-20Shea Jacqueline ElizabethBuy84.89K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 112, holders +5 vs prior quarter. Ownership 41.85%.

HolderSharesChangeChange %Value
FMR LLC8.45M-884.82K-9.47%9.30M
JUPITER TOPCO LLC5.17M5.17MNew5.71M
VANGUARD CAPITAL MANAGEMENT LLC3.65M749.35K+25.83%4.02M
BOXER CAPITAL MANAGEMENT, LLC2.84M474.87K+20.04%3.13M
ADAR1 CAPITAL MANAGEMENT, LLC2.14M673.80K+45.83%2.36M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.52M1.46M+2573.84%1.67M
D. E. SHAW & CO., INC.1.35M-861.16K-38.92%1.49M
TWO SIGMA INVESTMENTS, LP1.24M849.39K+217.58%1.36M
EVERSEPT PARTNERS, LP1.04M00.00%1.14M
GEODE CAPITAL MANAGEMENT, LLC802.75K1.25K+0.16%883.75K
MILLENNIUM MANAGEMENT LLC796.11K-614.74K-43.57%875.72K
BLACKROCK, INC.779.06K116.88K+17.65%856.96K
VANGUARD FIDUCIARY TRUST CO480.77K88.70K+22.62%528.85K
CAPTION MANAGEMENT, LLC478.95K478.95KNew526.85K
CAPTION MANAGEMENT, LLC400.00K400.00KNew440.00K
RENAISSANCE TECHNOLOGIES LLC361.34K-282.44K-43.87%397.47K
STATE STREET CORP336.61K40.30K+13.60%370.27K
CITADEL ADVISORS LLC319.50K257.60K+416.16%351.45K
TUDOR INVESTMENT CORP ET AL300.00K300.00KNew330.00K
DIADEMA PARTNERS LP275.20K200.00K+265.96%302.72K
GSA CAPITAL PARTNERS LLP265.01K-64-0.02%292.00K
UBS GROUP AG262.32K12.67K+5.08%288.55K
QUADRATURE CAPITAL LTD258.93K258.93KNew284.82K
CITADEL ADVISORS LLC241.78K179.88K+290.59%265.95K
STONEPINE CAPITAL MANAGEMENT, LLC1.35M1.35MNew210.18K

Earnings and financials

Inovio Pharmaceuticals, Inc. (INO) trades at $0.93, with a market cap of $64.41M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Inovio Pharmaceuticals (INO) Financials: Revenue & Earnings

INO$0.93+0.04 +4.74%

$64.41M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History